CN101098705A - 草药组合物phy906及其在化学治疗中的应用 - Google Patents

草药组合物phy906及其在化学治疗中的应用 Download PDF

Info

Publication number
CN101098705A
CN101098705A CNA2005800461878A CN200580046187A CN101098705A CN 101098705 A CN101098705 A CN 101098705A CN A2005800461878 A CNA2005800461878 A CN A2005800461878A CN 200580046187 A CN200580046187 A CN 200580046187A CN 101098705 A CN101098705 A CN 101098705A
Authority
CN
China
Prior art keywords
phy906
treatment
cpt
day
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800461878A
Other languages
English (en)
Chinese (zh)
Inventor
Y-C·程
S-H·刘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of CN101098705A publication Critical patent/CN101098705A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2005800461878A 2004-11-09 2005-11-09 草药组合物phy906及其在化学治疗中的应用 Pending CN101098705A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62594304P 2004-11-09 2004-11-09
US60/625,943 2004-11-09
US11/100,433 2005-04-07
US11/100,433 US7534455B2 (en) 2000-03-09 2005-04-07 Herbal composition PHY906 and its use in chemotherapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201410401772.6A Division CN104161832A (zh) 2004-11-09 2005-11-09 草药组合物phy906及其在化学治疗中的应用

Publications (1)

Publication Number Publication Date
CN101098705A true CN101098705A (zh) 2008-01-02

Family

ID=36337179

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA2005800461878A Pending CN101098705A (zh) 2004-11-09 2005-11-09 草药组合物phy906及其在化学治疗中的应用
CN201410401772.6A Pending CN104161832A (zh) 2004-11-09 2005-11-09 草药组合物phy906及其在化学治疗中的应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201410401772.6A Pending CN104161832A (zh) 2004-11-09 2005-11-09 草药组合物phy906及其在化学治疗中的应用

Country Status (8)

Country Link
US (1) US7534455B2 (cg-RX-API-DMAC7.html)
EP (1) EP1812028A4 (cg-RX-API-DMAC7.html)
JP (1) JP5057987B2 (cg-RX-API-DMAC7.html)
CN (2) CN101098705A (cg-RX-API-DMAC7.html)
AU (1) AU2005304493B2 (cg-RX-API-DMAC7.html)
CA (1) CA2583761C (cg-RX-API-DMAC7.html)
TW (1) TW200630105A (cg-RX-API-DMAC7.html)
WO (1) WO2006053049A2 (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970299A (zh) * 2017-11-16 2018-05-01 饶本强 一种清热解毒抗肿瘤复方制剂
CN109475540A (zh) * 2016-06-22 2019-03-15 耶鲁大学 用于植物药的基于机理的质量控制
CN115397468A (zh) * 2020-03-30 2022-11-25 耶鲁大学 治疗炎性和纤维化疾病和病症的方法
US20240306981A1 (en) * 2020-05-19 2024-09-19 Peachy Corp. Systems and methods for preventing and treating wrinkles

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871279B2 (en) 2000-03-09 2014-10-28 Yale University Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
US8394365B2 (en) * 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
CN101730535A (zh) 2007-02-15 2010-06-09 耶鲁大学 草药组合物phy906及其在化疗中的用途
TWI361075B (en) * 2007-03-16 2012-04-01 Brion Res Inst Of Taiwan Pharmaceutical composition for inhibiting the syndrome of snore
US20110111070A1 (en) 2007-10-25 2011-05-12 Yung-Chi Cheng Use of phy906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome
WO2011150175A2 (en) * 2010-05-26 2011-12-01 President And Fellows Of Harvard College Compositions and methods for pain reduction
US8541382B2 (en) 2010-11-13 2013-09-24 Sirbal Ltd. Cardiac glycoside analogs in combination with emodin for cancer therapy
US8734859B1 (en) 2010-11-13 2014-05-27 Sirbal Ltd. Molecular combinations for cancer or other disease treatment
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US20170049835A1 (en) 2015-07-29 2017-02-23 Sirbal Ltd. Herbal Combinations For Treating Scalp Conditions
EP3498288A1 (en) 2013-12-02 2019-06-19 Sirbal Ltd. Herbal combinations for treatment of a skin condition
CN109414422A (zh) * 2016-05-23 2019-03-01 耶鲁大学 使用包含phy906提取物、黄芩提取物或来自这些提取物的化合物的联合疗法改善抗免疫检查点抑制剂的治疗指数
US10086026B2 (en) 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
JP7132344B2 (ja) 2018-02-28 2022-09-06 チュンアン・ユニヴァーシティ・インダストリー・アカデミック・コーペレーション・ファウンデーション 悪液質および筋損失の予防、改善または治療用組成物
CN110105149B (zh) * 2019-04-23 2022-02-01 来宾市农业科学院 一种蚕沙防治甘蔗螟虫的方法
CN109991341B (zh) * 2019-05-17 2022-04-01 无限极（中国）有限公司 一种制首乌的质量检测方法
JP2023504202A (ja) * 2019-12-09 2023-02-01 イエール ユニバーシティ がんの再発を予防するための組成物および方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936621A (ja) * 1982-08-25 1984-02-28 Tsumura Juntendo Inc 脂肪分解促進作用阻害剤
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
US6630176B2 (en) * 2000-03-07 2003-10-07 Mount Sinai School Of Medicine Of New York University Herbal remedies for treating allergies and asthma
JP5064630B2 (ja) * 2000-03-09 2012-10-31 エール ユニヴァーシティ 薬草組成物ｐｈｙ９０６および化学療法におけるその使用
WO2002007743A2 (de) * 2000-07-26 2002-01-31 Vitaplant Ag Piper methysticum pflanzenextrakt

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109475540A (zh) * 2016-06-22 2019-03-15 耶鲁大学 用于植物药的基于机理的质量控制
US11517605B2 (en) 2016-06-22 2022-12-06 Yale University Mechanism based quality control for botanical medicine
CN107970299A (zh) * 2017-11-16 2018-05-01 饶本强 一种清热解毒抗肿瘤复方制剂
CN115397468A (zh) * 2020-03-30 2022-11-25 耶鲁大学 治疗炎性和纤维化疾病和病症的方法
US20240306981A1 (en) * 2020-05-19 2024-09-19 Peachy Corp. Systems and methods for preventing and treating wrinkles

Also Published As

Publication number Publication date
CA2583761C (en) 2015-04-21
TW200630105A (en) 2006-09-01
US7534455B2 (en) 2009-05-19
US20050196473A1 (en) 2005-09-08
WO2006053049A3 (en) 2007-03-22
AU2005304493B2 (en) 2012-05-10
CA2583761A1 (en) 2006-05-18
AU2005304493A1 (en) 2006-05-18
EP1812028A4 (en) 2010-01-20
CN104161832A (zh) 2014-11-26
WO2006053049A2 (en) 2006-05-18
JP5057987B2 (ja) 2012-10-24
JP2008519767A (ja) 2008-06-12
EP1812028A2 (en) 2007-08-01

Similar Documents

Publication Publication Date Title
JP5064630B2 (ja) 薬草組成物ｐｈｙ９０６および化学療法におけるその使用
CN101098705A (zh) 草药组合物phy906及其在化学治疗中的应用
US20050129780A1 (en) Relief of aids symptoms
US20130101688A1 (en) Herbal composition phy906 and its use in chemotherapy
US20070041993A1 (en) Compositions and methods for symptomatic relief
CN101918017A (zh) Phy906用于治疗炎性肠病和/或肠易激综合征的用途
CN100490789C (zh) 一种治疗癌症的中药肠溶胶囊剂的用途
CN101062374B (zh) 一种治疗癌症的中药组合物胶囊的制备方法及其产品
AU2001245508B2 (en) Compositions consisting of PHY906 and chemotherapeutic agents
HK1111910A (en) Herbal composition phy906 and its use in chemotherapy
CN112516276A (zh) 预防新型冠状病毒肺炎的中药及其制备工艺和中药饮品
CN104510912B (zh) 一种治疗气滞血瘀型慢性乙型肝炎的中药及制备方法
CN119074858A (zh) 一种治疗白血病的组合物及其制备方法、应用
HK1077737A (en) Herbal composition phy906 and its use in chemotheraphy
CN103120711B (zh) 一种治疗肝炎的药物组合物、制备方法及新用途
CN1981812A (zh) 一种治疗艾滋病的中药制剂及其制备方法
CN103157063A (zh) 一种抑制肿瘤的中药复方制剂及其制备方法
CN104524091A (zh) 一种治疗病毒性肝炎的组合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1111910

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20080102